Sahar Salehi

Karolinska University Hospital, Karolinska Institutet

Papers

6

Total Citations

477

H-Index

5

About

Dr. Sahar Salehi is a pioneering gynecologic oncologist whose research is reshaping surgical staging for high-risk endometrial and cervical cancers. Her work centers on minimally invasive, robot-assisted techniques and sentinel lymph node (SLN) mapping to reduce morbidity without compromising oncologic outcomes. Dr. Salehi led the landmark SHREC-trial (237 citations), which prospectively validated the diagnostic accuracy of a pelvic SLN algorithm in high-risk endometrial cancer, providing the evidence needed to shift practice from systematic lymphadenectomy to targeted SLN biopsy. She also spearheaded the RACC trial (150 citations), an international randomized controlled study comparing robot-assisted versus open surgery for cervical cancer, and demonstrated the feasibility of robotic para-aortic lymphadenectomy in high-risk patients. Her work has been cited over 470 times, reflecting its profound impact on surgical standards. Dr. Salehi’s contributions extend to documenting long-term outcomes, including lymphedema and rare complications, ensuring that innovation is paired with rigorous safety evaluation. Her research is a cornerstone for surgeons seeking to offer patients less invasive, evidence-based staging.

Research Focus

Key Achievements

5
H-Index
6
Papers
477
Total Citations
80
Avg Citations/Paper
🏆 Most Cited Paper
Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)—the final step towards a paradigm shift in surgical staging
237 citations · 2019
📈 Most Prolific Year: 2019 (3 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Karolinska University Hospital, Karolinska Institutet

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago